Back to GetFilings.com



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

ý                                 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2005

 

OR

 

o                                 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                        to                        

 

Commission File No. 000-51072

 

CASCADE MICROTECH, INC.

(Exact name of registrant as specified in its charter)

 

Oregon

 

93-0856709

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

2430 N.W. 206th Avenue
Beaverton, Oregon

 

97006

(Address of principal executive offices)

 

(Zip Code)

 

 

 

Registrant’s telephone number, including area code: (503) 601-1000

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ý   No  o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

Yes  o   No  ý

 

The number of shares of common stock outstanding as of May 9, 2005 was 10,867,693.

 

 



 

CASCADE MICROTECH, INC.

INDEX TO FORM 10-Q

 

PART I - FINANCIAL INFORMATION

 

 

 

Item 1.

Financial Statements

 

 

 

 

 

Condensed Consolidated Balance Sheets (unaudited) - March 31, 2005 and December 31, 2004

 

 

 

 

 

Condensed Consolidated Statements of Operations (unaudited) - Three Months Ended March 31, 2005 and 2004

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows (unaudited) - Three Months Ended March 31, 2005 and 2004

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements (unaudited)

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

 

 

Item 4.

Controls and Procedures

 

 

 

 

PART II - OTHER INFORMATION

 

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

 

 

 

Item 6.

Exhibits

 

 

 

 

Signatures

 

 

1



 

PART I - FINANCIAL INFORMATION

 

Item 1.  Financial Statements

 

Cascade Microtech, Inc.

Condensed Consolidated Balance Sheets

(Unaudited, In thousands)

 

 

 

March 31,
2005

 

December 31,
2004 (1)

 

Assets

 

 

 

 

 

Current Assets:

 

 

 

 

 

Cash and cash equivalents

 

$

1,311

 

$

2,033

 

Short-term marketable securities

 

42,182

 

41,714

 

Accounts receivable, net

 

14,905

 

13,640

 

Inventories, net

 

10,828

 

10,180

 

Prepaid expenses and other

 

2,005

 

1,579

 

Deferred income taxes

 

1,776

 

1,552

 

Total Current Assets

 

73,007

 

70,698

 

 

 

 

 

 

 

Long-term marketable securities

 

4,303

 

2,779

 

Fixed assets, net

 

3,786

 

4,008

 

Deferred income taxes

 

229

 

65

 

Other assets, net

 

1,533

 

1,466

 

Total Assets

 

$

82,858

 

$

79,016

 

 

 

 

 

 

 

Liabilities and Shareholders’ Equity

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

Current portion of long-term debt and capital leases

 

$

20

 

$

21

 

Accounts payable

 

4,270

 

3,951

 

Deferred revenue

 

578

 

579

 

Accrued liabilities

 

3,813

 

2,609

 

Total Current Liabilities

 

8,681

 

7,160

 

 

 

 

 

 

 

Long-term debt and capital leases

 

8

 

14

 

Deferred revenue

 

307

 

282

 

Other long-term liabilities

 

1,275

 

1,372

 

Total Liabilities

 

10,271

 

8,828

 

 

 

 

 

 

 

Shareholders’ Equity:

 

 

 

 

 

Common stock

 

109

 

109

 

Additional paid-in capital

 

55,324

 

55,402

 

Deferred stock-based compensation

 

(269

)

(310

)

Accumulated other comprehensive loss - unrealized holding losses on investments

 

(76

)

(17

)

Retained earnings

 

17,499

 

15,004

 

Total Shareholders’ Equity

 

72,587

 

70,188

 

Total Liabilities and Shareholders’ Equity

 

$

82,858

 

$

79,016

 

 


(1) Derived from Cascade Microtech’s audited financial statements as of December 31, 2004.

 

See accompanying Notes to Consolidated Financial Statements.

 

2



 

Cascade Microtech, Inc.

Condensed Consolidated Statements of Operations

(Unaudited, In thousands, except per share amounts)

 

 

 

For the Quarter Ended March 31,

 

 

 

2005

 

2004

 

Revenue

 

$

18,661

 

$

13,834

 

 

 

 

 

 

 

Cost of sales

 

9,490

 

7,935

 

Deferrred stock-based compensation

 

12

 

19

 

Gross profit

 

9,159

 

5,880

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

Research and development (excludes $4 and $8, respectively, of amortization of deferred stock-based compensation)

 

1,639

 

1,389

 

Selling, general and administrative (excludes $25 and $93, respectively, of amortization of deferred stock-based compensation)

 

4,599

 

3,787

 

Deferred stock compensation

 

29